Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank79
3Y CAGR+57.2%
5Y CAGR+29.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+57.2%/yr
vs -50.0%/yr prior
5Y CAGR
+29.7%/yr
Recent acceleration
Acceleration
+107.2pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
3.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $174.93M | +141.9% |
| 2024 | $72.31M | +215.0% |
| 2023 | $22.95M | -49.0% |
| 2022 | $45.01M | +130.5% |
| 2021 | $19.52M | -59.0% |
| 2020 | $47.62M | -33.4% |
| 2019 | $71.54M | -90.0% |
| 2018 | $718.38M | +256.2% |
| 2017 | $201.66M | +43.0% |
| 2016 | $141.05M | - |